Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BAD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | BAD |
| Aliases | Page for BAD Gene |
| Chromosome | 11q13.1 |
| Function | BAD is a BH3-only pro-apoptotic BCL-2 family member |
| Pathways | Apoptosis, Differentiation, Er Stress, Immune Response, Synaptic Plasticity |
| UniProt ID | Q92934 |
| NCBI Gene ID | 573 |
| GeneCards | BAD |
| Human Protein Atlas | BAD |
| Associated Diseases | AD, Als, Alzheimer, Cancer, fibrosis |
| Interactions | AGING, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMBRA1, AMPK |
| KG Connections | 491 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
BAD["BAD
(BCL2 Associated
Agonist of Cell Death)"]
BAD -->|"activates"| APOP["Apoptosis
Cell Death"]
BAD -->|"associated_with"| FERRO["Ferroptosis
Iron-dependent
Cell Death"]
BAD -->|"regulates"| ISCH["Ischemic
Damage"]
BAD -->|"associated_with"| NEUROINF["Neuroinflammation"]
APOP -->|"contributes_to"| ALS["ALS
(Motor Neuron
Degeneration)"]
APOP -->|"contributes_to"| PD["Parkinson's
Disease"]
APOP -->|"contributes_to"| AD["Alzheimer's
Disease"]
APOP -->|"contributes_to"| MS["Multiple
Sclerosis"]
FERRO -->|"promotes"| NEURODEGENERATION["Neurodegeneration"]
NEUROINF -->|"accelerates"| NEURODEGENERATION
ISCH -->|"triggers"| NEURODEGENERATION
BAD -->|"therapeutic_target"| ALS_THERAPY["ALS Therapy
Development"]
BAD -->|"therapeutic_target"| PD_THERAPY["Parkinson's
Therapy"]
BAD -->|"therapeutic_target"| AD_THERAPY["Alzheimer's
Therapy"]
BAD -->|"therapeutic_target"| MS_THERAPY["MS Therapy
Development"]
BAD -->|"inhibits"| TUMOR["Tumor
Formation"]
BAD -->|"inhibits"| CANCER["Cancer
Progression"]
style BAD fill:#006494
style ALS_THERAPY fill:#1b5e20
style PD_THERAPY fill:#1b5e20
style AD_THERAPY fill:#1b5e20
style MS_THERAPY fill:#1b5e20
style APOP fill:#ef5350
style FERRO fill:#ef5350
style NEUROINF fill:#ef5350
style NEURODEGENERATION fill:#5d4400
style ALS fill:#5d4400
style PD fill:#5d4400
style AD fill:#5d4400
style MS fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| apoptosis | activates | phenotype | 0.90 |
| apoptosis | promotes | process | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Apoptosis | associated_with | process | 0.80 |
| BAX | interacts_with | protein | 0.80 |
| Skin Fibrosis | associated_with | phenotype | 0.80 |
| BCL-2 | activates | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Ischemia | regulates | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Autophagy | activates | pathway | 0.70 |
| Wnt | activates | pathway | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| CANCER | activates | gene | 0.70 |
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| OXIDATIVE STRESS | activates | gene | 0.70 |
| CANCER | associated_with | gene | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| Tumor | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Ischemia | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Lymphoma | inhibits | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Cardiac | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Heart Failure | therapeutic_target | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Leukemia | therapeutic_target | disease | 0.65 |
| Cardiac | regulates | disease | 0.65 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.65 |
| Hypertension | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BAX | activates | gene | 0.90 |
| Separating Microneedles | downregulates | compound | 0.85 |
| 5-fluorouracil | downregulates | drug | 0.80 |
| TP53 | regulates | gene | 0.70 |
| BAX | interacts_with | gene | 0.70 |
| AMBRA1 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| AKT | phosphorylates | entity | 0.60 |
| TLR2 | associated_with | gene | 0.60 |
| TRKB | causes | gene | 0.60 |
| JNK | causes | gene | 0.60 |
| MTOR | causes | gene | 0.60 |
| AKT | causes | gene | 0.60 |
| PI3K | causes | gene | 0.60 |
| BDNF | causes | gene | 0.60 |
| TAU | causes | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| IFN | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| AGING | inhibits | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | therapeutic_target | gene | 0.60 |
| SYNAPTIC PRUNING | therapeutic_target | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| IFN-Γ | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | associated_with | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| LAMP2 | associated_with | gene | 0.60 |
| TFRC | associated_with | gene | 0.60 |
| PPP1CB | associated_with | gene | 0.60 |
| TLR2 | therapeutic_target | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| BID | associated_with | gene | 0.60 |
| PI3K | inhibits | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| TP53 | causes | gene | 0.60 |
| BCL-2 | regulates | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| ERK | inhibits | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| JAK | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| ROS | regulates | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| IL-17 | associated_with | gene | 0.60 |
| HER2 | inhibits | gene | 0.60 |
| FERROPTOSIS | associated_with | gene | 0.60 |
| PSME3 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning BAD in their description or question text
No additional research found